The research team projects that the Pathological Diagnosis market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Quest Diagnostics
StageBio
Unilabs
Sonic Healthcare
Pathologists Diagnostic
Lab Corp
DIAN Diagnose
BML
SYNLAB International
Kingmed
ADICON
Huayin Lab
By Type
Histopathology
Cell Pathology
Immunohistochemical pathology
Molecular Pathology
By Application
Hospital
Diagnostic Laboratories
Other
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland
South Asia
India
Pakistan
Bangladesh
Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar
Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman
Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo
Oceania
Australia
New Zealand
South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador
Rest of the World
Kazakhstan
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Pathological Diagnosis 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Pathological Diagnosis Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the Pathological Diagnosis Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pathological Diagnosis market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Pathological Diagnosis Market Size Analysis from 2022 to 2027
1.5.1 Global Pathological Diagnosis Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Pathological Diagnosis Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Pathological Diagnosis Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Pathological Diagnosis Industry Impact
Chapter 2 Global Pathological Diagnosis Competition by Types, Applications, and Top Regions and Countries
2.1 Global Pathological Diagnosis (Volume and Value) by Type
2.1.1 Global Pathological Diagnosis Consumption and Market Share by Type (2016-2021)
2.1.2 Global Pathological Diagnosis Revenue and Market Share by Type (2016-2021)
2.2 Global Pathological Diagnosis (Volume and Value) by Application
2.2.1 Global Pathological Diagnosis Consumption and Market Share by Application (2016-2021)
2.2.2 Global Pathological Diagnosis Revenue and Market Share by Application (2016-2021)
2.3 Global Pathological Diagnosis (Volume and Value) by Regions
2.3.1 Global Pathological Diagnosis Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Pathological Diagnosis Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Pathological Diagnosis Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Pathological Diagnosis Consumption by Regions (2016-2021)
4.2 North America Pathological Diagnosis Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Pathological Diagnosis Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Pathological Diagnosis Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Pathological Diagnosis Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Pathological Diagnosis Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Pathological Diagnosis Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Pathological Diagnosis Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Pathological Diagnosis Sales, Consumption, Export, Import (2016-2021)
4.10 South America Pathological Diagnosis Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Pathological Diagnosis Market Analysis
5.1 North America Pathological Diagnosis Consumption and Value Analysis
5.1.1 North America Pathological Diagnosis Market Under COVID-19
5.2 North America Pathological Diagnosis Consumption Volume by Types
5.3 North America Pathological Diagnosis Consumption Structure by Application
5.4 North America Pathological Diagnosis Consumption by Top Countries
5.4.1 United States Pathological Diagnosis Consumption Volume from 2016 to 2021
5.4.2 Canada Pathological Diagnosis Consumption Volume from 2016 to 2021
5.4.3 Mexico Pathological Diagnosis Consumption Volume from 2016 to 2021
Chapter 6 East Asia Pathological Diagnosis Market Analysis
6.1 East Asia Pathological Diagnosis Consumption and Value Analysis
6.1.1 East Asia Pathological Diagnosis Market Under COVID-19
6.2 East Asia Pathological Diagnosis Consumption Volume by Types
6.3 East Asia Pathological Diagnosis Consumption Structure by Application
6.4 East Asia Pathological Diagnosis Consumption by Top Countries
6.4.1 China Pathological Diagnosis Consumption Volume from 2016 to 2021
6.4.2 Japan Pathological Diagnosis Consumption Volume from 2016 to 2021
6.4.3 South Korea Pathological Diagnosis Consumption Volume from 2016 to 2021
Chapter 7 Europe Pathological Diagnosis Market Analysis
7.1 Europe Pathological Diagnosis Consumption and Value Analysis
7.1.1 Europe Pathological Diagnosis Market Under COVID-19
7.2 Europe Pathological Diagnosis Consumption Volume by Types
7.3 Europe Pathological Diagnosis Consumption Structure by Application
7.4 Europe Pathological Diagnosis Consumption by Top Countries
7.4.1 Germany Pathological Diagnosis Consumption Volume from 2016 to 2021
7.4.2 UK Pathological Diagnosis Consumption Volume from 2016 to 2021
7.4.3 France Pathological Diagnosis Consumption Volume from 2016 to 2021
7.4.4 Italy Pathological Diagnosis Consumption Volume from 2016 to 2021
7.4.5 Russia Pathological Diagnosis Consumption Volume from 2016 to 2021
7.4.6 Spain Pathological Diagnosis Consumption Volume from 2016 to 2021
7.4.7 Netherlands Pathological Diagnosis Consumption Volume from 2016 to 2021
7.4.8 Switzerland Pathological Diagnosis Consumption Volume from 2016 to 2021
7.4.9 Poland Pathological Diagnosis Consumption Volume from 2016 to 2021
Chapter 8 South Asia Pathological Diagnosis Market Analysis
8.1 South Asia Pathological Diagnosis Consumption and Value Analysis
8.1.1 South Asia Pathological Diagnosis Market Under COVID-19
8.2 South Asia Pathological Diagnosis Consumption Volume by Types
8.3 South Asia Pathological Diagnosis Consumption Structure by Application
8.4 South Asia Pathological Diagnosis Consumption by Top Countries
8.4.1 India Pathological Diagnosis Consumption Volume from 2016 to 2021
8.4.2 Pakistan Pathological Diagnosis Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Pathological Diagnosis Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Pathological Diagnosis Market Analysis
9.1 Southeast Asia Pathological Diagnosis Consumption and Value Analysis
9.1.1 Southeast Asia Pathological Diagnosis Market Under COVID-19
9.2 Southeast Asia Pathological Diagnosis Consumption Volume by Types
9.3 Southeast Asia Pathological Diagnosis Consumption Structure by Application
9.4 Southeast Asia Pathological Diagnosis Consumption by Top Countries
9.4.1 Indonesia Pathological Diagnosis Consumption Volume from 2016 to 2021
9.4.2 Thailand Pathological Diagnosis Consumption Volume from 2016 to 2021
9.4.3 Singapore Pathological Diagnosis Consumption Volume from 2016 to 2021
9.4.4 Malaysia Pathological Diagnosis Consumption Volume from 2016 to 2021
9.4.5 Philippines Pathological Diagnosis Consumption Volume from 2016 to 2021
9.4.6 Vietnam Pathological Diagnosis Consumption Volume from 2016 to 2021
9.4.7 Myanmar Pathological Diagnosis Consumption Volume from 2016 to 2021
Chapter 10 Middle East Pathological Diagnosis Market Analysis
10.1 Middle East Pathological Diagnosis Consumption and Value Analysis
10.1.1 Middle East Pathological Diagnosis Market Under COVID-19
10.2 Middle East Pathological Diagnosis Consumption Volume by Types
10.3 Middle East Pathological Diagnosis Consumption Structure by Application
10.4 Middle East Pathological Diagnosis Consumption by Top Countries
10.4.1 Turkey Pathological Diagnosis Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Pathological Diagnosis Consumption Volume from 2016 to 2021
10.4.3 Iran Pathological Diagnosis Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Pathological Diagnosis Consumption Volume from 2016 to 2021
10.4.5 Israel Pathological Diagnosis Consumption Volume from 2016 to 2021
10.4.6 Iraq Pathological Diagnosis Consumption Volume from 2016 to 2021
10.4.7 Qatar Pathological Diagnosis Consumption Volume from 2016 to 2021
10.4.8 Kuwait Pathological Diagnosis Consumption Volume from 2016 to 2021
10.4.9 Oman Pathological Diagnosis Consumption Volume from 2016 to 2021
Chapter 11 Africa Pathological Diagnosis Market Analysis
11.1 Africa Pathological Diagnosis Consumption and Value Analysis
11.1.1 Africa Pathological Diagnosis Market Under COVID-19
11.2 Africa Pathological Diagnosis Consumption Volume by Types
11.3 Africa Pathological Diagnosis Consumption Structure by Application
11.4 Africa Pathological Diagnosis Consumption by Top Countries
11.4.1 Nigeria Pathological Diagnosis Consumption Volume from 2016 to 2021
11.4.2 South Africa Pathological Diagnosis Consumption Volume from 2016 to 2021
11.4.3 Egypt Pathological Diagnosis Consumption Volume from 2016 to 2021
11.4.4 Algeria Pathological Diagnosis Consumption Volume from 2016 to 2021
11.4.5 Morocco Pathological Diagnosis Consumption Volume from 2016 to 2021
Chapter 12 Oceania Pathological Diagnosis Market Analysis
12.1 Oceania Pathological Diagnosis Consumption and Value Analysis
12.2 Oceania Pathological Diagnosis Consumption Volume by Types
12.3 Oceania Pathological Diagnosis Consumption Structure by Application
12.4 Oceania Pathological Diagnosis Consumption by Top Countries
12.4.1 Australia Pathological Diagnosis Consumption Volume from 2016 to 2021
12.4.2 New Zealand Pathological Diagnosis Consumption Volume from 2016 to 2021
Chapter 13 South America Pathological Diagnosis Market Analysis
13.1 South America Pathological Diagnosis Consumption and Value Analysis
13.1.1 South America Pathological Diagnosis Market Under COVID-19
13.2 South America Pathological Diagnosis Consumption Volume by Types
13.3 South America Pathological Diagnosis Consumption Structure by Application
13.4 South America Pathological Diagnosis Consumption Volume by Major Countries
13.4.1 Brazil Pathological Diagnosis Consumption Volume from 2016 to 2021
13.4.2 Argentina Pathological Diagnosis Consumption Volume from 2016 to 2021
13.4.3 Columbia Pathological Diagnosis Consumption Volume from 2016 to 2021
13.4.4 Chile Pathological Diagnosis Consumption Volume from 2016 to 2021
13.4.5 Venezuela Pathological Diagnosis Consumption Volume from 2016 to 2021
13.4.6 Peru Pathological Diagnosis Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Pathological Diagnosis Consumption Volume from 2016 to 2021
13.4.8 Ecuador Pathological Diagnosis Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Pathological Diagnosis Business
14.1 Quest Diagnostics
14.1.1 Quest Diagnostics Company Profile
14.1.2 Quest Diagnostics Pathological Diagnosis Product Specification
14.1.3 Quest Diagnostics Pathological Diagnosis Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 StageBio
14.2.1 StageBio Company Profile
14.2.2 StageBio Pathological Diagnosis Product Specification
14.2.3 StageBio Pathological Diagnosis Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Unilabs
14.3.1 Unilabs Company Profile
14.3.2 Unilabs Pathological Diagnosis Product Specification
14.3.3 Unilabs Pathological Diagnosis Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Sonic Healthcare
14.4.1 Sonic Healthcare Company Profile
14.4.2 Sonic Healthcare Pathological Diagnosis Product Specification
14.4.3 Sonic Healthcare Pathological Diagnosis Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Pathologists Diagnostic
14.5.1 Pathologists Diagnostic Company Profile
14.5.2 Pathologists Diagnostic Pathological Diagnosis Product Specification
14.5.3 Pathologists Diagnostic Pathological Diagnosis Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Lab Corp
14.6.1 Lab Corp Company Profile
14.6.2 Lab Corp Pathological Diagnosis Product Specification
14.6.3 Lab Corp Pathological Diagnosis Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 DIAN Diagnose
14.7.1 DIAN Diagnose Company Profile
14.7.2 DIAN Diagnose Pathological Diagnosis Product Specification
14.7.3 DIAN Diagnose Pathological Diagnosis Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 BML
14.8.1 BML Company Profile
14.8.2 BML Pathological Diagnosis Product Specification
14.8.3 BML Pathological Diagnosis Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 SYNLAB International
14.9.1 SYNLAB International Company Profile
14.9.2 SYNLAB International Pathological Diagnosis Product Specification
14.9.3 SYNLAB International Pathological Diagnosis Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Kingmed
14.10.1 Kingmed Company Profile
14.10.2 Kingmed Pathological Diagnosis Product Specification
14.10.3 Kingmed Pathological Diagnosis Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 ADICON
14.11.1 ADICON Company Profile
14.11.2 ADICON Pathological Diagnosis Product Specification
14.11.3 ADICON Pathological Diagnosis Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Huayin Lab
14.12.1 Huayin Lab Company Profile
14.12.2 Huayin Lab Pathological Diagnosis Product Specification
14.12.3 Huayin Lab Pathological Diagnosis Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Pathological Diagnosis Market Forecast (2022-2027)
15.1 Global Pathological Diagnosis Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Pathological Diagnosis Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Pathological Diagnosis Value and Growth Rate Forecast (2022-2027)
15.2 Global Pathological Diagnosis Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Pathological Diagnosis Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Pathological Diagnosis Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Pathological Diagnosis Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Pathological Diagnosis Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Pathological Diagnosis Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Pathological Diagnosis Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Pathological Diagnosis Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Pathological Diagnosis Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Pathological Diagnosis Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Pathological Diagnosis Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Pathological Diagnosis Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Pathological Diagnosis Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Pathological Diagnosis Consumption Forecast by Type (2022-2027)
15.3.2 Global Pathological Diagnosis Revenue Forecast by Type (2022-2027)
15.3.3 Global Pathological Diagnosis Price Forecast by Type (2022-2027)
15.4 Global Pathological Diagnosis Consumption Volume Forecast by Application (2022-2027)
15.5 Pathological Diagnosis Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
The Third-party Pathology Diagnosis Center Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
The Myocarditis Treatment and Diagnosis Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
The Concussion Treatment and Diagnosis Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
The Image-based FFR Diagnosis Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...
The Donor Transfusion Diagnosis Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The new DRG is a mixed payment method in which the NHIS pays for medical expenses incurred during a single medical treatment, dividing the cost of procedures, drugs, and therapeutic materials into all-inclusive and non-inclusive fees.
Most medical services are comprehensively bundled together...
Asia Pacific connected healthcare device market will grow by 21.1% annually with a total addressable market cap of $495.3 billion over 2024-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetrat...
Europe connected healthcare device market was valued at $16 billion in 2023 and will grow by 19.2% annually over 2023-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetration of mobile and inte...
North America connected healthcare device market is projected to grow by 18.9% annually in the forecast period and reach $106.9 billion by 2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetrati...
Global connected healthcare device market will reach $338.6 billion by 2033, growing by 19.5% annually over 2023-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetration of mobile and internet ...